07:00 , Jul 16, 2015 |  BC Innovations  |  Finance

Foundation in disrepair

The multiple sclerosis community will lose one of its advocates for investing in research on reversing the disease when the Myelin Repair Foundation (MRF) closes its doors next month due to lack of funding that...
08:00 , Mar 4, 1996 |  BC Week In Review  |  Company News

AccuMed, Difco Laboratories Inc. diagnostics/imaging news

ACMI, formerly Alamar Biosciences Inc., settled its civil action with Difco. Alamar sued Difco and Difco's Pasco Laboratories subsidiary in 1994, alleging that the companies had misappropriated Alamar's trade secrets pertaining to its bacterial...
08:00 , Jan 8, 1996 |  BC Week In Review  |  Company News

AccuMed, Alamar deal

The companies completed their merger (see BioCentury Feb. 21, 1995). AccuMed shareholders will receive 2.43 shares of ALMR stock for each share of AccuMed shares owned, resulting in 16.9 million shares in the combined company....
08:00 , Dec 11, 1995 |  BC Week In Review  |  Company News

Alamar Inc., Difco Laboratories Inc. diagnostics/imaging news

ALMR said the U.S. District Court for the Eastern District of California denied a motion by Difco for summary judgement on ALMR's claim that Difco misappropriated its trade secrets. In its 1994 action, ALMR alleged...
07:00 , Oct 23, 1995 |  BC Week In Review  |  Company News

Alamar, MicroScan diagnostics/imaging news

ALMR (Sacramento) said the U.S. District Court in Sacramento granted its motion for summary judgement against MicroScan, which had claimed ownership of ALMR's technology to determine bacterial susceptibility (see BioCentury Nov. 21, 1994). ...
07:00 , Oct 16, 1995 |  BC Week In Review  |  Clinical News

Alamar regulatory update

ALMR received notice of allowance for a U.S. patent covering its apparatus and methods for antimicrobial susceptibility testing of microorganisms. ALMR employs the technology in its alamarBlue redox technology. Alamar Biosciences Inc. (ALMR)   Business: Diagnostics/Imaging...
07:00 , Oct 16, 1995 |  BC Week In Review  |  Company News

Alamar, Becton, Dickinson and Co. deal

ALMR (Sacramento) completed its previously announced licensing agreement with Becton Dickinson for the use of alamarBlue redox indicator dye (see BioCentury May 15). Becton Dickinson paid $750,000 of the $3.5 million license fee, with the...
07:00 , Sep 5, 1995 |  BC Week In Review  |  Clinical News

Alamar regulatory update

The Sacramento, Calif., company receive a notice of allowance for a European patent covering ALMR's apparatus and methods for antimicrobial susceptibility testing of microorganisms using its alamarBlue redox technology. ALMR sells bacterial susceptibility and identification...
07:00 , May 15, 1995 |  BC Week In Review  |  Company News

Alamar deal

Alamar Biosciences Inc. (ALMR)   The Sacramento company signed a letter of intent with Becton Dickinson and Co.'s Microbiology Systems division under which ALMR will grant a semi-exclusive, worldwide license for its alamarBlue technology to...
07:00 , May 1, 1995 |  BC Week In Review  |  Company News

Alamar deal

ALMR (Sacramento) reached a definitive agreement to merge with AccuMed Inc. (Chicago), a privately held provider of of laboratory diagnostic products. Financial terms will be announced upon the completion of the merger in three to...